Susana Otero-Romero Selected Research

Susana Otero-Romero Research Topics

11	Multiple Sclerosis 04/2024 - 07/2015
7	COVID-19 04/2024 - 10/2021
4	Infections 09/2023 - 01/2021
3	Relapsing-Remitting Multiple Sclerosis 01/2022 - 01/2018
2	Asymptomatic Diseases 01/2022 - 01/2022
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
1	Rubella (German Measles) 12/2023
1	Herpes Zoster 12/2023
1	Measles 12/2023
1	Mumps 12/2023
1	Chickenpox 12/2023
1	Hepatitis B 09/2023
1	Neuromyelitis Optica (Devic's Disease) 09/2023
1	Disease Progression 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Stroke (Strokes) 12/2021
1	Epilepsy (Aura) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021

5	VaccinesIBA 04/2024 - 01/2021
3	Natalizumab (Tysabri)FDA Link 04/2024 - 01/2021
2	Messenger RNA (mRNA)IBA 04/2024 - 12/2021
2	ocrelizumabIBA 09/2023 - 01/2021
2	Rituximab (Mabthera)FDA Link 09/2023 - 01/2021
2	Oligoclonal BandsIBA 11/2022 - 07/2015
2	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 10/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2022
2	COVID-19 VaccinesIBA 01/2022 - 12/2021
2	Interferon-betaIBA 01/2021 - 01/2018
1	Attenuated VaccinesIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 09/2023
1	AntibodiesIBA 09/2023
1	ChAdOx1 nCoV-19IBA 08/2023
1	Immunoglobulin G (IgG)IBA 11/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Oral ContraceptivesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 12/2021
1	BNT162 VaccineIBA 12/2021
1	2-amino-4-hydroxybenzenesulfonic acidIBA 12/2021
1	teriflunomideIBA 01/2021
1	Dimethyl FumarateIBA 01/2021
1	Alemtuzumab (Campath)FDA Link 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021
1	Glatiramer Acetate (Copaxone)FDA Link 01/2021
1	InterferonsIBA 01/2018

4	Therapeutics 04/2024 - 01/2018
2	Treatment Delay 04/2024 - 11/2020
2	Injections 01/2022 - 01/2022
1	Aftercare (After-Treatment) 01/2023
1	Ambulatory Care (Outpatient Care) 01/2022
1	Time-to-Treatment 10/2021